MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202647106092 A) filed by Sumitomo Pharma Co. , Ltd.; and National Cancer Center on September 03, 2026, for Tertiary Amide Derivative Substituted With Four-Membered Ring Structure.
Inventors include Uesugi, Shunichiro; Kamei, Yusuke; Ban, Hitoshi Number; Kamioka, Seiji; Imazaki, Yusuke; Ogiwara, Hideaki; and Takeuchi, Mariko.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present disclosure provides: a tertiary amide derivative which is substituted with a four-membered ring structure and is useful as a medicine, and a pharmaceutically acceptable salt thereof; and a pharmaceutical composition comprising the components or an agent for treating or preventing pathoses involving CBP/P300, the agent comprising the composition. More specifically, the present disclosure provides a compound represented by formula (1) [in the formula, A represents CHF or CH2, B represents formula (B-1), the ring Q represents a six- to ten-membered aromatic hydrocarbon ring which may be substituted or a five- to ten- membered aromatic heterocyclic ring which may be substituted, Z represents –O-, -N(R7a)-, a six- to ten-membered divalent aromatic ring group which may be substituted, a five- to ten-membered divalent aromatic heterocyclic group which may be substituted, or a four- to ten-membered divalent non-aryl heterocyclic group which may be substituted, and R1, R2a, R2b, R3, R4, and R5 are as described in the specification] or a pharmaceutically acceptable salt thereof.
Disclaimer: Curated by HT Syndication.
